BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22750931)

  • 1. [Kidney and bone update : the 5-year history and future of CKD-MBD. Vascular calcification in CKD patients].
    Joki N; Iwasaki M
    Clin Calcium; 2012 Jul; 22(7):993-9. PubMed ID: 22750931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].
    Mori H; Okada Y; Tanaka Y; Hashimoto O
    Clin Calcium; 2012 Jul; 22(7):1034-42. PubMed ID: 22750936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
    Taniguchi M
    Clin Calcium; 2010 Jul; 20(7):1078-87. PubMed ID: 20585187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
    Hamano T
    Clin Calcium; 2012 Jul; 22(7):1043-9. PubMed ID: 22750937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of phosphate binders on vascular calcification].
    Hanafusa N
    Clin Calcium; 2015 May; 25(5):711-21. PubMed ID: 25926575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease--mineral and bone disorder: a complex scenario.
    Mejía N; Roman-García P; Miar AB; Tavira B; Cannata-Andía JB
    Nefrologia; 2011; 31(5):514-9. PubMed ID: 21959717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
    Mizobuchi M; Nakazawa A; Akizawa T
    Clin Calcium; 2011 Dec; 21(12):159-66. PubMed ID: 22133835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic kidney disease (CKD) and bone. Impact of diabetes mellitus on the development of CKD-MBD].
    Inaba M
    Clin Calcium; 2009 Apr; 19(4):502-7. PubMed ID: 19329828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney and bone update : the 5-year history and future of CKD-MBD. Disorders of musculoskeletal system in CKD ; bone fracture and periarticular calcification].
    Yamada S; Taniguchi M
    Clin Calcium; 2012 Jul; 22(7):1000-7. PubMed ID: 22750932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic kidney disease (CKD) and bone. From renal osteodystrophy to CKD-MBD: new disease entity].
    Tsukamoto Y
    Clin Calcium; 2009 Apr; 19(4):479-84. PubMed ID: 19329825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
    Russo D; Bellasi A; Pota A; Russo L; Di Iorio B
    J Nephrol; 2015 Feb; 28(1):73-80. PubMed ID: 24599830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder.
    Tanaka H; Komaba H; Koizumi M; Kakuta T; Fukagawa M
    J Ren Nutr; 2012 Jan; 22(1):98-101. PubMed ID: 22200424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].
    Uemura K; Kakuta T
    Clin Calcium; 2010 Jul; 20(7):1104-10. PubMed ID: 20585190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.
    London G; Coyne D; Hruska K; Malluche HH; Martin KJ
    Clin Nephrol; 2010 Dec; 74(6):423-32. PubMed ID: 21084045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
    Imanishi Y
    Clin Calcium; 2012 Jul; 22(7):1025-33. PubMed ID: 22750935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.